Clinical Trial

Registry of Patients Living With Type 1 Diabetes

Recruiting
View on ClinicalTrials.gov →
Summary
A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc. Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2018-10-22; most recent amendment 2025-02-24.
Status change: Not Yet Recruiting → Recruiting 2019-03-26
Trial Details
NCT Number NCT03720197
Lead Sponsor Institut de Recherches Cliniques de Montreal
Conditions Type 1 Diabetes Mellitus
Enrollment 6,000 participants
Start Date 2019-02-20
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-25